Spirometry Interpretation: Borderline Obstruction Requiring Post-Bronchodilator Testing
Your spirometry shows borderline obstruction (FEV1/FVC 73%) that requires post-bronchodilator testing to confirm or rule out COPD, followed by repeat spirometry in 3-6 months if the post-bronchodilator ratio normalizes. 1
Initial Assessment
Your pre-bronchodilator values show:
- FEV1/FVC ratio of 73% (0.73) - This is below the 0.7 threshold but within the critical "gray zone" of 0.60-0.80
- FEV1 75% predicted - Mildly reduced
- FVC 77% predicted - Mildly reduced
This pattern indicates possible airflow obstruction, but the diagnosis cannot be confirmed without post-bronchodilator spirometry. 1
Required Next Step: Post-Bronchodilator Testing
The GOLD 2025 guidelines are explicit: when pre-bronchodilator FEV1/FVC is <0.7, you must perform post-bronchodilator spirometry to confirm the diagnosis. 1 This is critical because:
- Approximately 17% of patients with pre-bronchodilator obstruction normalize after bronchodilator (flow responders)
- A small percentage (~3%) only show obstruction after bronchodilator (volume responders)
- Your FEV1/FVC of 0.73 falls in the range where biological variation can change the diagnostic conclusion 1
Post-Bronchodilator Interpretation Algorithm:
If post-BD FEV1/FVC ≥0.7 (normalizes):
- You are a "flow responder" (PREO-POSTN pattern)
- Close follow-up required with repeat spirometry in 3-6 months 1
- Nearly 50% of flow responders progress to persistent obstruction
- Higher risk if you smoke or have FEV1/FVC values close to 0.7
- A larger bronchodilator response (>12% and >200ml improvement in FEV1 or FVC) indicates greater risk for subsequent COPD development 1
If post-BD FEV1/FVC <0.7 (remains obstructed):
- COPD diagnosis confirmed
- Severity grading based on post-BD FEV1% predicted
- Your FEV1 of 75% would indicate GOLD Stage 2 (moderate) if obstruction persists
Confirmation Testing
Because your post-BD FEV1/FVC ratio falls between 0.60 and 0.80, repeat spirometry on a separate occasion is recommended to confirm the diagnosis regardless of whether it shows obstruction or not. 1 This accounts for biological variation that can affect measurements. The suggested timeframe is 3-6 months, guided by clinical status.
Important Clinical Context Needed
The interpretation depends heavily on:
- Smoking history or other inhalational exposures - COPD diagnosis requires risk factor exposure
- Respiratory symptoms (dyspnea, chronic cough, sputum production)
- Age - The fixed 0.7 ratio may overdiagnose obstruction in elderly patients (>60 years), where up to 35% may be false positives 2
Age-Related Caveat:
If you are over 60 years old, the FEV1/FVC ratio naturally declines with age. Using the fixed 0.7 threshold may lead to overdiagnosis. 3, 2 However, GOLD 2025 maintains the 0.7 threshold when combined with appropriate clinical context (symptoms and exposures), and post-bronchodilator testing reduces this overdiagnosis risk. 1
Why Both Pre- and Post-BD Testing Matters
Your lower FEV1 (<80% predicted) increases the likelihood you could be a volume responder - someone with gas trapping where bronchodilator increases FVC, potentially revealing obstruction that wasn't apparent pre-bronchodilator. 1 This is why post-BD testing is particularly important when baseline FEV1 is reduced.
Quality Control Note
Ensure your spirometry was performed to acceptable quality standards (ideally Grade A with three acceptable measurements). 1 If quality was suboptimal, repeat testing is even more important to confirm findings.
Bottom line: Perform post-bronchodilator spirometry immediately, then plan repeat testing in 3-6 months regardless of the post-BD result, given your borderline values. 1